![Carole Faig](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carole Faig
Direttore/Membro del Consiglio presso
HENRY SCHEIN, INC.
Patrimonio netto: 614 555 $ in data 31/05/2026
Profilo
Carole T.
Faig currently works at Henry Schein, Inc., as Independent Director from 2023, QuVa Pharma, Inc., as Director, Affinia Therapeutics, Inc., as Independent Director from 2021, Program for Appropriate Technology in Health, as Director from 2022, and The Scan Group, Inc., as Director from 2025.
Ms. Faig also formerly worked at Cue Health, Inc., as Independent Director from 2021 to 2024 and Ernst & Young LLP, as Partner from 1997 to 2020.
Ms. Faig received her undergraduate degree from Sam Houston State University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
HENRY SCHEIN, INC. 0,01% | 23/03/2026 | 8.025 ( 0,01% ) | 614 555 $ | 31/05/2026 |
Posizioni attive di Carole Faig
| Società | Posizione | Inizio |
|---|---|---|
| HENRY SCHEIN, INC. | Direttore/Membro del Consiglio | 18/12/2023 |
Affinia Therapeutics, Inc.
 Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Direttore/Membro del Consiglio | 01/09/2021 |
QuVa Pharma, Inc.
 QuVa Pharma, Inc. Medical SpecialtiesHealth Technology Manufactures sterile injectable products | Direttore/Membro del Consiglio | - |
Program for Appropriate Technology in Health
 Program for Appropriate Technology in Health Miscellaneous Commercial ServicesCommercial Services Provides social healthcare services | Direttore/Membro del Consiglio | 01/12/2022 |
The Scan Group, Inc.
 The Scan Group, Inc. Advertising/Marketing ServicesCommercial Services Provides advertising, digital marketing, graphic design and printing services | Direttore/Membro del Consiglio | 01/02/2025 |
Precedenti posizioni note di Carole Faig
| Società | Posizione | Fine |
|---|---|---|
| CUE HEALTH INC. | Direttore/Membro del Consiglio | 24/05/2024 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | 01/01/2020 |
Formazione di Carole Faig
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
97
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Henry Schein, Inc.
 Henry Schein, Inc. Medical DistributorsDistribution Services Distributes healthcare products and services | Distribution Services |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Sam Houston State University
 Sam Houston State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Program for Appropriate Technology in Health
Program for Appropriate Technology in Health Miscellaneous Commercial ServicesCommercial Services Provides social healthcare services | Commercial Services |
The Scan Group, Inc.
The Scan Group, Inc. Advertising/Marketing ServicesCommercial Services Provides advertising, digital marketing, graphic design and printing services | Commercial Services |
Cue Health, Inc.
 Cue Health, Inc. Medical SpecialtiesHealth Technology Develops a wireless diagnostic device that enables consumers to run clinical lab tests at home to measure their own health | Health Technology |
QuVa Pharma, Inc.
QuVa Pharma, Inc. Medical SpecialtiesHealth Technology Manufactures sterile injectable products | Health Technology |
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Health Technology |
